Literature DB >> 1663804

Breast cancer genetic evolution: I. Data from cytogenetics and DNA content.

B Dutrillaux1, M Gerbault-Seureau, Y Remvikos, B Zafrani, M Prieur.   

Abstract

A general scheme of chromosome alterations occurring during tumor progression is proposed from the cytogenetic study of 113 breast carcinomas. For 76 of these tumors, chromosome numbers and rate of chromosome rearrangements were correlated with DNA content studied by flow cytometry. A series of 536 cases was used as control for flow cytometry. The following evolution can be proposed: 1. occurrence of unbalanced rearrangements decreasing chromosome number and DNA content; 2. correlatively to the rate of chromosome rearrangements, formation of endoreduplications leading to hyperploid sidelines; 3. persistence of the near diploid cells and decrease of chromosome number to about 35 and of DNA index to .85; 4. more frequently, elimination of the near diploid cells and complete passage to hyperploidy; 5. further losses of chromosomes in the hyperploid tumors, whose karyotypes can decrease to about 55 chromosomes and a DNA index of 1.35; 6. eventually, occurrence of a second endoreduplication, leading to an apparent near tetraploidy. The rate of rearranged chromosomes may reach 80% in both near diploid tumors with 35-40 and hyperploid tumors with 55-65 chromosomes which can be regarded as those with the highest degree of tumor progression. It is shown that the increase of chromosome number and DNA index above diploidy is very limited, and that all tumors with more than 50 chromosomes and 1.35 DNA content passed through endoreduplication. This results in many possible losses of heterozygosity in these cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663804     DOI: 10.1007/bf01961161

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  [Comparative cytogenetic study of 7 types of mammary cancer].

Authors:  N Ayraud; J C Lambert; K Hufferman-Tribollet; B Basteris
Journal:  Ann Genet       Date:  1977-09

2.  Preferential involvement of chromosome 1q in a primary breast carcinoma.

Authors:  G Kovacs
Journal:  Cancer Genet Cytogenet       Date:  1981-03

3.  Common cytogenetic findings in primary breast cancer.

Authors:  A D Ferti-Passantonopoulou; A D Panani
Journal:  Cancer Genet Cytogenet       Date:  1987-08

4.  Cytogenetics of colorectal adenocarcinomas.

Authors:  M Muleris; R J Salmon; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1990-06

5.  Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.

Authors:  O P Kallioniemi; G Blanco; M Alavaikko; T Hietanen; J Mattila; K Lauslahti; M Lehtinen; T Koivula
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

6.  Chromosome imbalance in endometrial adenocarcinoma.

Authors:  J Couturier; P Vielh; R J Salmon; M Lombard; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1988-07-01

7.  Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy.

Authors:  Y Remvikos; P Beuzeboc; A Zajdela; N Voillemot; H Magdelénat; P Pouillart
Journal:  J Natl Cancer Inst       Date:  1989-09-20       Impact factor: 13.506

8.  Recurrent HSR in the centromeric region of chromosome 8 in breast cancer.

Authors:  M Gerbault-Seureau; P Vielh; B Dutrillaux
Journal:  Ann Genet       Date:  1987

9.  Long-term storage of samples for flow cytometric DNA analysis.

Authors:  L L Vindeløv; I J Christensen; N Keiding; M Spang-Thomsen; N I Nissen
Journal:  Cytometry       Date:  1983-03

10.  Relevance of DNA ploidy as a measure of genetic deviation: a comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer.

Authors:  Y Remvikos; M Gerbault-Seurreau; P Vielh; B Zafrani; H Magdelénat; B Dutrillaux
Journal:  Cytometry       Date:  1988-11
View more
  30 in total

1.  Persistent telomere damage induces bypass of mitosis and tetraploidy.

Authors:  Teresa Davoli; Eros Lazzerini Denchi; Titia de Lange
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

2.  Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization.

Authors:  H Tsuda; T Takarabe; N Susumu; J Inazawa; S Okada; S Hirohashi
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer.

Authors:  S Chevillard; A Müller; C Levalois; C Lainé-Bidron; P Vielh; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 4.  Development of cancer-initiating cells and immortalized cells with genomic instability.

Authors:  Ken-Ichi Yoshioka; Yuko Atsumi; Hitoshi Nakagama; Hirobumi Teraoka
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

5.  Relation between deletion of chromosome 1p36 and DNA ploidy in breast carcinoma: an interphase cytogenetic study.

Authors:  F Farabegoli; N Baldini; D Santini; C Ceccarelli; M Taffurelli; D Treré; M Derenzini
Journal:  Clin Mol Pathol       Date:  1996-04

6.  Induction of endocycles represses apoptosis independently of differentiation and predisposes cells to genome instability.

Authors:  Christiane Hassel; Bingqing Zhang; Michael Dixon; Brian R Calvi
Journal:  Development       Date:  2013-11-27       Impact factor: 6.868

7.  Improved detection of DNA aneuploidy in primary breast cancer using quantitative DNA image analysis in combination with fluorescent in situ hybridization technique.

Authors:  B Verdoodt; P Castelain; C Bourgain; M Kirsch-Volders
Journal:  Histochem J       Date:  1995-01

8.  Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis.

Authors:  Lydia Nakopoulou; Effie G Panayotopoulou; Ioanna Giannopoulou; Ioanna Tsirmpa; Sophia Katsarou; Eleni Mylona; Paraskevi Alexandrou; Antonios Keramopoulos
Journal:  J Clin Pathol       Date:  2007-07       Impact factor: 3.411

9.  Genetic evolution of breast cancer: II. Relationship with estrogen and progesterone receptor expression.

Authors:  H Magdelenat; M Gerbault-Seureau; C Laine-Bidron; M Prieur; B Dutrillaux
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

10.  Near-diploid hyperploidy in early breast cancer (T1a,b) is associated with higher risk of lymph node involvement.

Authors:  Joško Bezić; Ivana Samija-Projić; Petar Projić; Jelena Ljubković; Sandra Tomaš-Zekić; Maja Marinović-Guić; Snježana Tomić
Journal:  Pathol Oncol Res       Date:  2012-08-28       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.